Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy

Blood and Lymphatic Cancer: Targets and Therapy

COPE logo
ISSN: 1179-9889

Journal Image

Editor-in-Chief: Dr Wilson Gonsalves

An international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

Latest articles:

- 5 records -

Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study

Yan C, Huang Y, Cai Q, Li X, Yang Q, Feng G, Yang H, Chen Y, Hu J

Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:612305

Published Date: 16 June 2026

Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia

Kolosova A, Mould IA, Pepper C, Mitchell S, Pepper AG, Ladikou EE, Simoes FA

Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:511758

Published Date: 19 May 2026


Read more articles